| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.66 | 0.01 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |